Pharma Diagnostics develops a unique drug discovery screening technology based on localised surface plasmon resonance and noble metal nanoparticles in solution. The platform is high throughput, highly sensitive, label-free and requires no specialist instrumentation. It is particularly relevant to fragment screening and antibody screening.